Hurdles to Artificial Intelligence Deployment: Noise in Schemas and "Gold" Labels

人工智能部署的障碍:模式中的噪声和“黄金”标签

阅读:1

Abstract

Despite frequent reports of imaging artificial intelligence (AI) that parallels human performance, clinicians often question the safety and robustness of AI products in practice. This work explores two underreported sources of noise that negatively affect imaging AI: (a) variation in labeling schema definitions and (b) noise in the labeling process. First, the overlap between the schemas of two publicly available datasets and a third-party vendor are compared, showing there is low agreement (<50%) between them. The authors also highlight the problem of label inconsistency, where different annotation schemas are selected for the same clinical prediction task; this results in inconsistent use of medical ontologies through intermingling or duplicate observations and diseases. Second, the individual radiologist annotations for the CheXpert test set are used to quantify noise in the labeling process. The analysis demonstrated that label noise varies by class, as agreement was high for pneumothorax and medical devices (percent agreement > 90%). Among low agreement classes (pneumonia, consolidation), the labels assigned as "ground truth" were unreliable, suggesting that the result of majority voting is highly dependent on which group of radiologists is assigned to annotation. Noise in labeling schemas and gold label annotations are pervasive in medical imaging classification and affect downstream clinical deployment. Possible solutions (eg, changes to task design, annotation methods, and model training) and their potential to improve trust in clinical AI are discussed. Keywords: Radiology AI, Dataset Creation, Noise in Datasets Supplemental material is available for this article. © RSNA, 2023 See also the commentary by Ursprung and Woitek in this issue.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。